Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2003
03/19/2003EP1292315A2 Methods and compositions using sulodexide for the treatment of diabetic nephropathy
03/19/2003EP1292314A2 Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of glycosaminoglycans
03/19/2003EP1292313A2 Methods for treating hepatitis delta virus infection with beta-l-2' deoxy-nucleosides
03/19/2003EP1292311A2 Combination therapy for the treatment of depression comprising an antidepressant and an ampa receptor potentiator
03/19/2003EP1292310A1 Novel anti-infectives
03/19/2003EP1292309A1 Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz
03/19/2003EP1292308A1 Alpha,beta-unsaturated sulfones for treating proliferative disorders
03/19/2003EP1292307A2 Method of treating pain using nalbuphine and opioid antagonists
03/19/2003EP1292306A2 A combination kit used in the treatment of malaria containing chloroquine and 3-(1-(((4-((6-methoxy-8-quinolinyl)amino)pentyl)amino)-ethylidene)-dihydro-2(3h)furanone
03/19/2003EP1292305A1 METHOD OF DOPAMINE INHIBITION USING i L-THREO /i -METHYLPHENIDATE
03/19/2003EP1292304A1 Zolpidem hemitartrate
03/19/2003EP1292303A1 A stable pharmaceutical formulation comprising torsemide modification ii
03/19/2003EP1292302A2 Method of treating cardiovascular disease using rapamycin
03/19/2003EP1292301A1 Treatment and prevention of cardiac insulin resistance associated conditions
03/19/2003EP1292300A1 Combinations od dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment fo diabete mellitus
03/19/2003EP1292299A2 New use of citreamicins
03/19/2003EP1292298A1 Intracorporeal medicaments for high energy phototherapeutic treatment of disease
03/19/2003EP1292297A1 Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition
03/19/2003EP1292296A1 Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect
03/19/2003EP1292295A1 Supplement to enhance fertility
03/19/2003EP1292294A1 Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism
03/19/2003EP1292293A1 Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same
03/19/2003EP1292292A1 Method for treating congestive heart failure
03/19/2003EP1292291A2 Use of c 4-c10 acids for preventing gram-negative bacterial infections
03/19/2003EP1292290A2 Pharmaceutical compositions comprising acryloyl distamycin derivatives and topoisomerase i and ii inhibitors
03/19/2003EP1292289A2 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
03/19/2003EP1292288A2 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury
03/19/2003EP1292286A1 Dry-powder pharmaceutical formulation for inhalation comprising alpha4-integrin antagonist
03/19/2003EP1292282A2 Improved injectable dispersions of propofol
03/19/2003EP1292281A1 Novel tiotropium-containing inhalation powder
03/19/2003EP1292279A1 The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
03/19/2003EP1292278A2 Preparations that contain an extract of the plant pistia stratiotes
03/19/2003EP1292277A1 Method for protecting human skin
03/19/2003EP1292213A1 A formula to manipulate blood glucose via the calculated ingestion of carbohydrate
03/19/2003EP1292186A1 Animal and cell models for type ii diabetes and their use
03/19/2003EP1278528A4 Nucleoside analogs with carboxamidine-modified bicyclic base
03/19/2003EP1257281A4 Nucleoside analogs with carboxamidine modified monocyclic base
03/19/2003EP1196190B1 Use of long-chain n-alkyl derivatives of deoxynojirimycin and a glucocerebrosidase enzyme for the manufacture of a medicament for the treatment of glycolipid storage diseases
03/19/2003EP1178984B1 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
03/19/2003EP1177195B1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
03/19/2003EP1177192B1 Antifungal ethers
03/19/2003EP1173179B1 Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent major depressive disorders
03/19/2003EP1157019B1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
03/19/2003EP1149106B1 4,5-azolo-oxindoles
03/19/2003EP1140088A4 Controlled/modified release oral methylphenidate formulations
03/19/2003EP1137671B1 Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions
03/19/2003EP1114049B1 3-bicycloindole compounds as 5-ht1d receptor ligands
03/19/2003EP1104765B1 Process for preparing n,n,6- trimethyl-2 -(4-methylphenyl)- imidazo-[1,2-a] -pyridine-3- acetamide and salts thereof
03/19/2003EP1102579B1 Medicinal aerosol formulations
03/19/2003EP1100470B1 Fast dissolving ibuprofen containing compositions having analgesic activity
03/19/2003EP1080069B1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
03/19/2003EP1077980B1 Epothilone derivatives, a method for the production thereof, and their use
03/19/2003EP1071410B8 Ionic aqueous composition containing levomenthol
03/19/2003EP1060162B1 Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors
03/19/2003EP1056768B1 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
03/19/2003EP1051655A4 Methods and apparatus for accelerated orthokeratology
03/19/2003EP1049702B1 Process for purifying a solution of an ampicillin pro-drug ester
03/19/2003EP1042314B1 Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides
03/19/2003EP1037637B1 Use of 5ht1a receptor antagonists for preventing and/or treating temporal lobe epilepsy
03/19/2003EP1014812B1 Smoking products containing antioxidants
03/19/2003EP1011686A4 Modulation of human mast cell activation
03/19/2003EP0973390A4 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease
03/19/2003EP0964678B1 Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions
03/19/2003EP0963370B1 Integrin antagonists
03/19/2003EP0957891B1 Reduction of hair growth
03/19/2003EP0952853B1 Conjugate comprising an active agent, a polypeptide and a polyether
03/19/2003EP0944636B1 PHENYL GLYOXAMIDES AS sPLA2 INHIBITORS
03/19/2003EP0934312B1 1,4-disubstituted piperazines
03/19/2003EP0931082B1 Nodulisporic acid derivatives
03/19/2003EP0918504B1 Use of genistein as a preventive agent against ultraviolet radiation induced skin photodamage and cancer
03/19/2003EP0917472B1 Antiprotozoal composition
03/19/2003EP0910409A4 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens
03/19/2003EP0900203B1 Quinoline derivatives, processes for their preparation, and their use as medicaments
03/19/2003EP0888309B1 Imidazole derivatives having affinity for alpha2 receptors activity
03/19/2003EP0876482B1 Il-13 receptor polypeptide
03/19/2003EP0874847B1 Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof
03/19/2003EP0874635B1 Nonimmunogenic platelet and red blood cell compositions
03/19/2003EP0871490B1 Branched hydrazone linkers
03/19/2003EP0865609B1 Method of diagnosing and treating epithelioma
03/19/2003EP0839157B1 Colostrum derived growth factor
03/19/2003EP0833644B1 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders
03/19/2003EP0831798B1 Use of selegiline to treat hearing loss in mammals
03/19/2003EP0800364B1 Transdermal administration of apomorphine
03/19/2003EP0768879B1 Thiadiazole compounds as d3 dopamine receptor ligands
03/19/2003EP0758245B1 Use of spiramycin for treating gastrointestinal disorders caused by h. pylori
03/19/2003EP0754035B1 Carotenoid agent for inhibiting the conversion of epithelial cells to melanomas
03/19/2003EP0736093B1 ANTISENSE NUCLEIC ACIDS FOR THE PREVENTION AND TREATMENT OF DISORDERS IN WHICH EXPRESSION OF c-erbB-2 PLAYS A ROLL
03/19/2003CN1404484A Pluraflavins and derivatives thereof, process for their preparation and use thereof
03/19/2003CN1404483A New AZa-indolyl derivatives
03/19/2003CN1404482A Pteridine compounds for the treatment of psoriasis
03/19/2003CN1404481A Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
03/19/2003CN1404480A Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes
03/19/2003CN1404479A Novel 1,3-dihydro-2H-indol-2-one derivatives their preparing method and the pharmceutical composition containing the same
03/19/2003CN1404478A Pyridinylimidazoles
03/19/2003CN1404477A 哌嗪和哌啶衍生物 Piperazine and piperidine derivatives
03/19/2003CN1404476A Glycosidase inhibitors and preparation thereof
03/19/2003CN1404475A Method for the preparation of citalopram
03/19/2003CN1404474A Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
03/19/2003CN1404473A Substituted 8,8a-dihydro-3aH-indeno [1,2-D] thiazoles, a method for their production and their use as medicaments
03/19/2003CN1404472A Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
1 ... 5531 5532 5533 5534 5535 5536 5537 5538 5539 5540 5541 5542 5543 5544 5545 5546 5547 5548 5549 5550 5551 ... 7860